Search Results

The Impact of Intestinal Microbiota and Toll-like Receptor 2 Signaling on α-Synuclein Pathology in Nontransgenic Mice Injected with α-Synuclein Preformed Fibrils.

• Authors : Koyanagi, Yukako; Kassai, Momoe; Yoneyama, Hiroshi

Subjects: TRANSGENIC mice; MICE; GUT microbiome

• Source: Microorganisms; Jan2024, Vol. 12 Issue 1, p106, 14p

Record details

From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.

• Authors : Toader, Corneliu; Dobrin, Nicolaie; Brehar, Felix-Mircea

Subjects: PATHOLOGY; NEURODEGENERATION; AMYOTROPHIC lateral sclerosis

• Source: International Journal of Molecular Sciences; Nov2023, Vol. 24 Issue 22, p16119, 32p

Record details

The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease.

• Authors : Yang, Dongming; Zhao, Deming; Ali Shah, Syed Zahid

Subjects: PARKINSON'S disease; PATHOLOGY; GUT microbiome

• Source: Frontiers in Neurology; 11/6/2019, Vol. 10, p1-13, 13p

Record details

Retinal electrophysiology in central nervous system disorders. A review of human and mouse studies.

• Authors : Constable, Paul A.; Lim, Jeremiah K. H.; Thompson, Dorothy A.

Subjects: CENTRAL nervous system; MACHINE learning; PARKINSON'S disease

• Source: Frontiers in Neuroscience; 2023, p1-30, 30p

Record details

Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research.

• Authors : Khan, Mohammad Ahmed; Haider, Nafis; Singh, Tanveer

Subjects: PARKINSON'S disease; DRUG target; BIOMARKERS

• Source: Metabolic Brain Disease; Mar2023, Vol. 38 Issue 3, p873-919, 47p

Record details

Cingulum and Uncinate Fasciculus Microstructural Abnormalities in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies.

• Authors : Rashidi, Fatemeh; Khanmirzaei, Mohammad Hossein; Hosseinzadeh, Farbod

Subjects: DIFFUSION tensor imaging; PARKINSON'S disease; DIAGNOSTIC imaging

• Source: Biology (2079-7737); Mar2023, Vol. 12 Issue 3, p475, 31p

Record details

Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.

• Authors : Nicastro, Nicolas; Nencha, Umberto; Burkhard, Pierre R.

Subjects: DOPAMINERGIC neurons; DOPAMINERGIC imaging; SINGLE-photon emission computed tomography

• Source: Journal of Neurochemistry; Feb2023, Vol. 164 Issue 3, p346-363, 18p

Record details

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson's Disease with Sleep Disorders.

• Authors : Wang, Li; Gao, Zheng; Chen, Gang

Subjects: PARKINSON'S disease; SLEEP disorders; ADENOSINES

• Source: Brain Sciences (2076-3425); Feb2023, Vol. 13 Issue 2, p200, 17p

Record details

Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems.

• Authors : Paccione, Nicola; Rahmani, Mahdieh; Barcia, Emilia

Subjects: ANTIPARKINSONIAN agents; BLOOD-brain barrier; PARKINSON'S disease

• Source: Pharmaceutics; Jan2023, Vol. 15 Issue 1, p13, 33p

Record details

Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson's disease: A retrospective study.

• Authors : Ogawa, Takuya; Kajiyama, Yuta; Ishido, Hideaki

Subjects: RAPID eye movement sleep; PARKINSON'S disease; SLEEP interruptions

• Source: PLoS ONE; 12/30/2022, Vol. 17 Issue 12, p1-15, 15p

Record details

Neuroinflammation and Immune Changes in Prodromal Parkinson's Disease and Other Synucleinopathies.

• Authors : Terkelsen, Miriam Højholt; Klaestrup, Ida H.; Hvingelby, Victor

Subjects: PARKINSON'S disease; NEUROINFLAMMATION; BEHAVIOR disorders

• Source: Journal of Parkinson's Disease; 2022Supplement, Vol. 12, pS149-S163, 15p

Record details

Frequency of Depressive Disorders in Parkinson's Disease: A Systematic Review and Meta-Analysis.

• Authors : Chendo, Ines; Silva, Carlos; Duarte, Gonçalo S.

Subjects: PARKINSON'S disease; MENTAL depression; MOVEMENT disorders

• Source: Journal of Parkinson's Disease; 2022, Vol. 12 Issue 5, p1409-1418, 10p

Record details

Rare disease curative care expenditure-financing scheme-health provider-beneficiary group analysis: an empirical study in Sichuan Province, China.

• Authors : Li, Jia; Yang, Lian; Zhang, Yitong

Subjects: RARE diseases; PATIENTS' families; PARKINSON'S diseaseSICHUAN Sheng (China); CHINA

• Source: Orphanet Journal of Rare Diseases; 10/8/2022, Vol. 17 Issue 1, p1-11, 11p

Record details

Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus Internus in Parkinson's Disease: A Meta-Analysis.

• Authors : Zhang, Song; Zi, Shumei; Xiong, Sihuai

Subjects: APATHY; DEEP brain stimulation; ONLINE information services

• Source: Parkinson's Disease (20420080); 10/3/2022, p1-8, 8p

Record details

Clinical parameters predict the effect of bilateral subthalamic stimulation on dynamic balance parameters during gait in Parkinson's disease.

• Authors : Kelemen, Andrea; Halász, László; Muthuraman, Muthuraman

Subjects: DYNAMIC balance (Mechanics); PARKINSON'S disease; THALAMIC nuclei

• Source: Frontiers in Neurology; 9/26/2022, Vol. 13, p1-9, 9p

Record details

Enhanced Plasmonic Biosensor Utilizing Paired Antibody and Label-Free Fe 3 O 4 Nanoparticles for Highly Sensitive and Selective Detection of Parkinson's α -Synuclein in Serum.

• Authors : Mandala, Samuel Husin Surya; Liu, Tai-Jan; Chen, Chiung-Mei

Subjects: IRON oxide nanoparticles; PLASMONICS; SURFACE plasmon resonance

• Source: Biosensors (2079-6374); Oct2021, Vol. 11 Issue 10, p402, 1p

Record details

Application of Neurotoxin-Induced Animal Models in the Study of Parkinson's Disease-Related Depression: Profile and Proposal.

• Authors : Mou, Ya-Kui; Guan, Li-Na; Yao, Xiao-Yan

Subjects: MENTAL depression; BIOLOGICAL models; BIOMARKERS

• Source: Frontiers in Aging Neuroscience; 5/13/2022, Vol. 14, p1-18, 18p

Record details

3D Printed Mini-Floating-Polypill for Parkinson's Disease: Combination of Levodopa, Benserazide, and Pramipexole in Various Dosing for Personalized Therapy.

• Authors : Windolf, Hellen; Chamberlain, Rebecca; Breitkreutz, Jörg

Subjects: PARKINSON'S disease; DOPA; DOSAGE forms of drugs

• Source: Pharmaceutics; May2022, Vol. 14 Issue 5, p931-931, 22p

Record details

Cerebrospinal Fluid TNF-α and Orexin in Patients With Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder.

• Authors : Yuan, Yuan; Zhang, Yimeng; Cheng, Yueyang

Subjects: RAPID eye movement sleep; PARKINSON'S disease; CEREBROSPINAL fluid

• Source: Frontiers in Neurology; 2/18/2022, Vol. 13, p1-7, 7p

Record details

Effect of intermittent theta-burst stimulation on akinesia and sensorimotor integration in patients with Parkinson's disease.

• Authors : Degardin, Adrian; Devos, David; Defebvre, Luc

Subjects: PARKINSON'S disease; TRANSCRANIAL magnetic stimulation; SENSORIMOTOR integration

• Source: European Journal of Neuroscience; Sep2012, Vol. 36 Issue 5, p2669-2678, 10p, 1 Diagram, 3 Charts, 4 Graphs

Record details

Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis.

• Authors : Gan, Jinghuan; Chen, Zhichao; Han, Jiuyan

Subjects: FRONTOTEMPORAL lobar degeneration; OLDER people; ALZHEIMER'S disease

• Source: Frontiers in Endocrinology; 11/17/2021, Vol. 12, p1-9, 9p

Record details

Cognitive Decline in Parkinson's Disease: A Subgroup of Extreme Decliners Revealed by a Data-Driven Analysis of Longitudinal Progression.

• Authors : Andersson, Sara; Josefsson, Maria; Stiernman, Lars J.

Subjects: PARKINSON'S disease; PATHOLOGICAL physiology; SYMPTOMS

• Source: Frontiers in Psychology; 9/9/2021, Vol. 12, p1-10, 10p

Record details

MRI Guided Focused Ultrasound-Mediated Delivery of Therapeutic Cells to the Brain: A Review of the State-of-the-Art Methodology and Future Applications.

• Authors : Ahmed, Nabid; Gandhi, Dheeraj; Melhem, Elias R.

Subjects: IMMUNOLOGIC diseases; INTRATHECAL injections; CENTRAL nervous system tumors

• Source: Frontiers in Neurology; 6/17/2021, Vol. 12, p1-16, 16p

Record details

Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.

• Authors : Bang, Yeojin; Lim, Juhee; Choi, Hyun Jin

• Source: Archives of Pharmacal Research; Jun2021, Vol. 44 Issue 6, p588-604, 17p

Record details

Global Variability in Deep Brain Stimulation Practices for Parkinson's Disease.

• Authors : Mahajan, Abhimanyu; Butala, Ankur; Okun, Michael S.

Subjects: DEEP brain stimulation; SUBTHALAMIC nucleus; PARKINSON'S disease

• Source: Frontiers in Human Neuroscience; 3/31/2021, pN.PAG-N.PAG, 12p

Record details

Frameless stereotaxy in subthalamic deep brain stimulation: 3-year clinical outcome.

• Authors : Piano, Carla; Bove, Francesco; Mulas, Delia

Subjects: DEEP brain stimulation; STEREOTAXIC techniques; BRAIN stimulation

• Source: Neurological Sciences; 2021, Vol. 42 Issue 1, p259-266, 8p, 1 Diagram, 1 Chart, 2 Graphs

Record details

Uncovering the Pharmacological Mechanism of Stemazole in the Treatment of Neurodegenerative Diseases Based on a Network Pharmacology Approach.

• Authors : Jing Zhang; Huajun Li; Yubo Zhang

Subjects: SERINE/THREONINE kinases; NEURODEGENERATION; PHARMACOLOGY

• Source: International Journal of Molecular Sciences; 1/15/2020, Vol. 21 Issue 2, p1-16, 16p, 5 Diagrams, 5 Charts

Record details

Young Onset Parkinson's Disease: A Modern and Tailored Approach.

• Authors : Post, Bart; van den Heuvel, Lieneke; van Prooije, Teije

Subjects: PARKINSON'S disease; DYSKINESIAS; ETIOLOGY of diseases

• Source: Journal of Parkinson's Disease; 2020 Supplement 1, Vol. 10, pS29-S36, 8p

Record details

Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity.

• Authors : Stanojlovic, Milos; Pallais Yllescas, Jean Pierre; Vijayakumar, Aarthi

• Source: Molecular Neurobiology; Dec2019, Vol. 56 Issue 12, p8435-8450, 16p

Record details

Fluctuating cognition in the Lewy body dementias.

• Authors : O'Dowd, Seán; Schumacher, Julia; Burn, David J

Subjects: LEWY body dementia; SLEEP disorders; COGNITION disorders

• Source: Brain: A Journal of Neurology; Nov2019, Vol. 142 Issue 11, p3338-3350, 13p

Record details

Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson's disease.

• Authors : Ying Wang; An-Qi Chen; Yan Xue

Subjects: OREXINS; PARKINSON'S disease; GLOBUS pallidus

• Source: American Journal of Physiology: Cell Physiology; Oct2019, Vol. 317 Issue 4, pC800-C812, 13p

Record details

Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease.

• Authors : Stanojlovic, Milos; Pallais, Jean Pierre; Kotz, Catherine M.

Subjects: PARKINSON'S disease; BEHAVIOR; NEURONS

• Source: Frontiers in Neuroscience; 7/30/2019, p1-14, 14p

Record details

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson's Diseases.

• Authors : Zhang, Jiaming; Li, Xiaoping; Li, Jia-Da

Subjects: PARKINSON'S disease; SYNUCLEINS; NEURODEGENERATION

• Source: Frontiers in Neuroscience; 4/18/2019, pN.PAG-N.PAG, 11p

Record details

The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson's Disease.

• Authors : Lorio, Sara; Sambataro, Fabio; Bertolino, Alessandro

Subjects: PARKINSON'S disease diagnosis; MAGNETIC resonance imaging of the brain; DISEASE progression

• Source: Frontiers in Aging Neuroscience; 3/15/2019, pN.PAG-N.PAG, 13p

Record details

Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease.

• Authors : Eisinger, Robert S.; Ramirez-Zamora, Adolfo; Carbunaru, Samuel

Subjects: IMPULSE control disorders; PARKINSON'S disease; DOPAMINE

• Source: Frontiers in Neurology; 2/26/2019, pN.PAG-N.PAG, 14p

Record details

A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.

• Authors : Merchant, Kalpana M.; Cedarbaum, Jesse M.; Brundin, Patrik

Subjects: MOLECULAR genetics; ALPHA-synuclein; PARKINSON'S disease

• Source: Journal of Parkinson's Disease; 2019, Vol. 9 Issue 1, p31-61, 31p

Record details

Orexin-A Exerts Neuroprotective Effects via OX1R in Parkinson's Disease.

• Authors : Liu, Mei-Fang; Xue, Yan; Liu, Cui

• Source: Frontiers in Neuroscience; 11/15/2018, pN.PAG-N.PAG, 18p

Record details

Computational systems biology approaches for Parkinson’s disease.

• Authors : Glaab, Enrico

Subjects: PARKINSON'S disease; SYSTEMS biology; NETWORK analysis (Communication)

• Source: Cell & Tissue Research; Jul2018, Vol. 373 Issue 1, p91-109, 19p

Record details

Locus coeruleus.

• Authors : Benarroch, Eduardo E.

Subjects: LOCUS coeruleus; NORADRENALINE; PARKINSON'S disease

• Source: Cell & Tissue Research; Jul2018, Vol. 373 Issue 1, p221-232, 12p

Record details

Gene therapy approaches in the non-human primate model of Parkinson’s disease.

• Authors : Pignataro, D.; Sucunza, D.; Rico, A. J.

Subjects: MACAQUES; GENE therapy; BASAL ganglia diseases

• Source: Journal of Neural Transmission; Mar2018, Vol. 125 Issue 3, p575-589, 15p

Record details

Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.

• Authors : He, Naying; Huang, Pei; Ling, Huawei

• Source: NMR in Biomedicine; Apr2017, Vol. 30 Issue 4, pn/a-N.PAG, 8p

Record details

The Proteasome Inhibition Model of Parkinson's Disease.

• Authors : Bentea, Eduard; Verbruggen, Lise; Massie, Ann

Subjects: PROTEASOME inhibitors; PROTEASOMES; ANTINEOPLASTIC agents

• Source: Journal of Parkinson's Disease; 2017, Vol. 7 Issue 1, p31-63, 33p

Record details

Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.

• Authors : Li, Song; Dong, Jie; Cheng, Cheng

Subjects: PARKINSON'S disease treatment; NEURODEGENERATION; NEURONS

• Source: Journal of Neural Transmission; Nov2016, Vol. 123 Issue 11, p1279-1299, 21p

Record details

Pre-motorické a non-motorické príznaky Parkinsonovej choroby - taxonómia, klinická manifestácia a neuropatologické koreláty.

• Authors : Kurčová, S.; Menšíková, K.; Kaiserová, M.

• Source: Česká a Slovenská Neurologie a Neurochirurgie; 2016, Issue 3, p255-270, 16p

Record details

The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease.

• Authors : D'Ostilio, Kevin; Garraux, Gaëtan

Subjects: QUALITY of life; NEURAL stimulation; COGNITIVE therapy

• Source: Frontiers in Human Neuroscience; 4/22/2016, p1-10, 10p

Record details

Role of iron in neurodegenerative diseases.

• Authors : Li, Kai; Reichmann, Heinz

Subjects: NEURODEGENERATION; IRON in the body; DISEASE progression

• Source: Journal of Neural Transmission; Apr2016, Vol. 123 Issue 4, p389-399, 11p

Record details

Prevalence of depression in Parkinson’s disease in a Lebanese tertiary clinic.

• Authors : Ghaddar, Alissar; Fawaz, Mohammad; Khazen, Georges

Subjects: AGE factors in disease; SEX factors in diseaseLEBANON

• Source: Journal of Clinical & Experimental Neuropsychology; Jan2016, Vol. 38 Issue 1, p51-58, 8p, 2 Charts

Record details

El cuadro neurocognitivo y neuropsiquiátrico de la enfermedad de Parkinson.

• Authors : Ana Natalia, Seubert-Ravelo; Ma Guillermina, Yáñez-Téllez

• Source: Revista Mexicana de Neurociencia; ene/feb2016, Vol. 17 Issue 1, p65-75, 11p

Record details

Risk of Parkinson's disease following anxiety disorders: a nationwide population-based cohort study.

• Authors : Lin, C. ‐ H.; Lin, J. ‐ W.; Liu, Y. ‐ C.

Subjects: PARKINSON'S disease; DISEASE risk factors; ANXIETY disorders

• Source: European Journal of Neurology; Sep2015, Vol. 22 Issue 9, p1280-1287, 8p, 1 Diagram, 4 Charts

Record details

Depression in Parkinson's disease: the effectiveness and risk of pharmacotherapy. Clinical review.

• Authors : Dyduch, Agnieszka; Załuska, Maria

Subjects: ANTIDEPRESSANTS; BUPROPION; MENTAL depression

• Source: Psychogeriatrics; Jun2015, Vol. 15 Issue 2, p147-153, 7p, 1 Chart

Record details